Evaluation of low-dose proton beam radiation efficiency in MIA PaCa-2 pancreatic cancer cell line vitality and H2AX formation

Medicina (Lithuania)

Volumn 51, Issue 5, 2015, Pages 302-306

  Liubavičiute, Aušra ^a   Kraśko, Jan Aleksander ^b   Mlynska, Agata ^b   Lagzdina, Jelena ^b,c   Sužiedelis, Kestutis ^b   Pašukoniene, Vita ^b  

^a State Research Institute Centre for Innovative Medicine   (Lithuania)

^b NATIONAL CANCER INSTITUTE   (Lithuania)

^c CENTER FOR PHYSICAL SCIENCES AND TECHNOLOGY   (Lithuania)

Author keywords

Double strand breaks; Gamma H2AX; MIA PaCa 2; Non homologous end joining; Proton irradiation

Indexed keywords

HISTONE;

APOPTOSIS; CELL CYCLE; CELL SURVIVAL; EVALUATION STUDY; HUMAN; METABOLISM; PANCREATIC NEOPLASMS; PROCEDURES; PROTON THERAPY; RADIATION RESPONSE; TUMOR CELL LINE;

APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; HISTONES; HUMANS; PANCREATIC NEOPLASMS; PROTON THERAPY;

EID: 84962385356     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.medici.2015.10.002     Document Type: Article

References (20)

1. Iovanna J., Mallmann M.C., Gonçalves A., Turrini O., Dagorn J.C. Current knowledge on pancreatic cancer. Front Oncol 2012, 2:6.
2. Foote R.L.1, Stafford S.L., Petersen I.A., Pulido J.S., Clarke M.J., Schild S.E., et al. The clinical case for proton beam therapy. Radiat Oncol 2012, 7:174.
3. Lundkvista J., Ekmanb M., Ericssonc S.R., Isacssonc U., Jonssond B., Glimelius B. Economic evaluation of proton radiation therapy in the treatment of breast cancer. Radiother Oncol 2005, 75(2):179-185.
4. Wilson R.R. Radiological use of fast protons. Radiology 1946, 47(5):487-491.
5. Finnberg N., Wambi C., Ware J.H., Kennedy A.R., El-Deiry W.S. Gamma-radiation (GR) triggers a unique gene expression profile associated with cell death compared to proton radiation (PR) in mice in vivo. Cancer Biol Ther 2008, 7(12):2023-2033.
6. Montelius A., Blomquist E., Naeser P., Brahme A., Carlsson J., Carlsson A.C., et al. The narrow proton beam therapy unit at the Svedberg Laboratory in Uppsala. Acta Oncol 1991, 30(6):739-745.
7. Galloway N.R., Aspe J.R., Sellers C., Wall N.R. Enhanced antitumor effect of combined gemcitabine and proton radiation in the treatment of pancreatic cancer. Pancreas 2009, 38(7):782-790.
8. Nichols R.C., George T.J., Zaiden R.A., Awad Z.T., Asbun H.J., Huh S., et al. Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity. Acta Oncol 2013, 52(3):498-505.
9. Morgan W.F., Sowa M.B. Effects of ionizing radiation in nonirradiated cells. Proc Natl Acad Sci U S A 2005, 102(40):14127-14128.
10. Han W., Yu K.N. Response of cells to ionizing radiation. Adv Biomed Sci Eng 2009, 204-262.
11. Jarmalaite S. Laogoneksteles ciklo genetika (genetics of cell cycle) 2008, Technologija, Kaunas.
12. Khalil H.S., Tummala H., Chakarov S., Zhelev N., Lane D.P., Targeting A.T.M. pathway for therapeutic intervention in cancer. Biodiscovery 2012, 1:3.
13. Huang X., Darzynkiewicz Z. Cytometric assessment of histone H2AX phosphorylation: a reporter of DNA damage. Methods Mol Biol 2006, 314:73-80.
14. Lagzdina E., Gaspariunas M., Plukiene R., Plukis A., Pasukoniene V., Suziedelis K., et al. The application of 1.6MV proton microbeam to investigate radiation induced bystander effect in MIA PaCa-2 pancreatic cancer cell line. Med Phys Baltic States 2013, 1.
15. Jaroszeskl M.J., Humana R.H.O. Flow cytometry protocols. Methods in molecular biology 2003, vol. 91. Press Inc., Totowa.
16. Smart D.J., Ahmedi K.P., Harvey J.S., Lynch A.M. Genotoxicity screening via the γH2AX by flow assay. Mutat Res 2011, 715(1-2):25-31.
17. Borchiellini D., Etienne-Grimaldi M.C., Thariat J., Milano G. The impact of pharmacogenetics on radiation therapy outcome in cancer patients: a focus on DNA damage response genes. Cancer Treat Rev 2012, 38(6):737-759.
18. Kaliberov S.A., Buchsbaum D.J. Chapter seven - cancer treatment with gene therapy and radiation therapy. Adv Cancer Res 2012, 115:221-263.
19. Cong F., Goff S.P. c-Abl-induced apoptosis, but not cell cycle arrest, requires mitogen-activated protein kinase kinase 6 activation. Proc Natl Acad Sci U S A 1999, 96(24):13819-13824.
20. Schmid T.E., Zlobinskaya O., Multhoff G. Differences in phosphorylated histone H2AX foci formation and removal of cells exposed to low and high linear energy transfer radiation. Curr Genomics 2012, 13(6):418-425.